GT Biopharma's total assets for Q1 2026 were $10.00M, an increase of 23.32% from the previous quarter. GTBP total liabilities were $2.42M for the fiscal quarter, a 4.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.